Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services, LLC is recalling Fenofibrate 54 mg tablets that may have been mislabeled as Famciclovir 500 mg.
Aidapak Services is recalling Cilostazol 100 mg tablets due to a potential label mixup with Calcium Acetate capsules. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Fluvastatin Sodium 20 mg capsules because they may be mislabeled as Valsartan 80 mg tablets.
Ziemer USA Inc. is recalling five FEMTO LDV femtosecond surgical lasers because a controller board defect may cause the video monitor to overheat and shut off.
Aidapak Services, LLC is recalling Phenol Lozenges because they may have been mislabeled as Atorvastatin Calcium or Vitamin B Complex W/C tablets.
Aidapak Services, LLC is recalling Flecaainide Acetate tablets because they may be mislabeled as Colestipol HCL Micronized.
Aidapak Services, LLC is recalling Methocarbamol 500 mg tablets because they may have been mislabeled as Losartan Potassium 25 mg.
Aidapak Services, LLC is recalling specific lots of Fenofibrate 54 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets that may have been mislabeled as Multivitamin/Multimineral tablets.
Aidapak Services, LLC is recalling 403 tablets of Pyridoxine HCL 50 mg because they may have been mislabeled as other medications. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Aidapak Services is recalling Pancrelipase DR capsules because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Pregabalin 25 mg capsules because they may have been mislabeled as Cholecalciferol or Glyburide.
Aidapak Services is recalling 150 mg Irbesartan tablets because they may have been mislabeled as Benazepril HCl 40 mg.
Aidapak Services is recalling 50 mcg selenium tablets that may be mislabeled as guaifenesin ER 600 mg.
Kia is recalling 2014 Sportage vehicles because the certification label lists tire pressure 1 or 2 psi below the correct specification.
Aidapak Services is recalling Sulfasalazine 500 mg tablets because they may be mislabeled as Hyoscyamine Sulfate 0.125 mg.
Aidapak Services, LLC is recalling Cranberry Tablets, 450 mg, because they may be mislabeled as Metoprolol Succinate ER, 200 mg.
The Anspach Effort, Inc. is recalling all lots of MCA Cutting Burrs and Dissection Tools because the indications for use were broader than validated and directions were unclear.
Aidapak Services, LLC is recalling 2,998 tablets of Cholecalciferol 2000 units because they may be mislabeled as other medications.
Betachem, Inc. is recalling 27,000 kilos of Metformin Hydrochloride USP active pharmaceutical ingredient because it was not manufactured according to current good manufacturing practices.
Remel Inc is recalling Oxoid Antimicrobial Susceptibility Testing Discs because individual discs may not be sufficiently impregnated with antibiotic, resulting in smaller than expected zone sizes.
The Anspach Effort, Inc. is recalling MCA Cutting Burs because the current directions for use do not provide sufficient details regarding the intended use for these specific burs.
Aidapak Services is recalling Sertraline HCL 50 mg tablets because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Fexofenadine HCL 180 mg tablets because they may be mislabeled as Multivitamin/Multimineral tablets.
Aidapak Services, LLC is recalling Atenolol tablets that may be mislabeled as Vitamin B Complex or Piroxicam. The error involves specific pedigree codes and expiration dates.